Quick Answer
NEUROCRINE BIOSCIENCES INC reported Net Income Loss of $478.60 million for the year ending 2025.
- NEUROCRINE BIOSCIENCES INC showed an increase of +40.2% in Net Income Loss from 2024 to 2025.
- This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), NEUROCRINE BIOSCIENCES INC's Net Income Loss has grown by 1,037.7%.
- Historical annual values: Fiscal year 2025: $478.60 million | Fiscal year 2024: $341.30 million | Fiscal year 2023: $249.70 million | Fiscal year 2022: $154.50 million | Fiscal year 2021: $89.60 million | Fiscal year 2020: $407.30 million | Fiscal year 2019: $37.00 million | Fiscal year 2018: $21.10 million | Fiscal year 2017: -$142.54 million | Fiscal year 2016: -$141.09 million | Fiscal year 2015: -$88.93 million | Fiscal year 2014: -$60.54 million | Fiscal year 2013: -$46.09 million | Fiscal year 2012: $5.03 million | Fiscal year 2011: $37.57 million | Fiscal year 2010: -$7.97 million | Fiscal year 2009: -$51.04 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: